Results 231 to 240 of about 34,758 (354)

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, EarlyView.
What's New? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source

Genotoxic carcinogenicity of pyrrolizidine alkaloids: relevance of potency factors for the risk assessment. [PDF]

Arch Toxicol
Sachse B, Hessel-Pras S, Schäfer B.
europepmc   +1 more source

DNA Synthesis Inhibition in Mammalian Cells as a Test for Mutagenic Carcinogens

, 1981
Robert B. Painter
openalex   +2 more sources

The impact of tobacco cessation on buccal mucosa cancer risk: A multi‐centre case–control study in India

International Journal of Cancer, EarlyView.
What's New? While the association between tobacco consumption and oral cancer is well established, the effect of cessation, particularly of chewing tobacco, the most common tobacco product in South Asia, is understudied. This case–control study in an Indian population demonstrates that a longer duration of tobacco smoking and chewing cessation is ...
Gayathri B. Pullat, Bastian Bohrmann, Grace Sarah George, Shubham Dikshit, Arjun Singh, Pankaj Chaturvedi, Rajesh Dikshit, Sarah Lewington, Sharayu Mhatre   +8 more
wiley   +1 more source

Preclinical research models for evaluating the biocompatibility of bioresorbable metallic cardiovascular stents: A comparative review. [PDF]

Bioact Mater
Hansen S, Bui TA, Xu X, McGrath K.
europepmc   +1 more source

Mutagenicity tests with a permeable mutant of yeast on carcinogens showing false-negative in Salmonella assay.

, 1989
Tamotsu Morita, Yoshihisa Iwamoto, Tadayori Shimizu, Toshiyuki Masuzawa, Yasutake Yanagihara   +4 more
openalex   +2 more sources

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia, Anne‐Sophie van der Werf‐'t Lam, Madalina Cabuta, Maartje Nielsen, Noah C. Helderman   +4 more
wiley   +1 more source

Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities. [PDF]

Toxicol Sci
Guo X, Seo JE, Xu H, Yan J, Malhi P, Atrakchi AH, McGovern T, Davis Bruno KL, Heflich RH, Chen T.   +9 more
europepmc   +1 more source

Carcinogenicity Test

, 2016
J. H. Duffus
openalex   +2 more sources

Extended HPV typing as an efficient alternative within HPV‐based screening programs

International Journal of Cancer, EarlyView.
What's New? Extended high‐risk human papillomavirus (hrHPV) typing holds promise for improving cervical intraepithelial neoplasia grade 3 (CIN3) detection, particularly as vaccinated cohorts may shift the prevalence of oncogenic HPV types. The authors of this study evaluated extended hrHPV genotyping within a public screening program involving women ...
Joacim Meneses‐León, Berenice Rivera‐Paredez, Sonia Hernández‐Salazar, Leticia Torres‐Ibarra, Martha Carnalla, Leith León‐Maldonado, Rubí Hernández‐López, José Damián Cadena‐Fiscal, Anna B. Moscicki, Manuel Quiterio‐Trenado, Eduardo Lazcano‐Ponce, Jorge Salmerón   +11 more
wiley   +1 more source